UNSPSC 51161823: Althaea

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B3911G2Q52 and which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 21609 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Rosanae, Order Malvales, Family Malvaceae, and Genus Althaea L., more commonly known as MARSHMALLOW.

UNSPSC 51161823 Althaea is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies, specifically parenteral solutions, intravenous products, naloxone, and drug deactivation systems for health care delivery to correctional facilities, public health departments, and community health programs. The work spans sourcing, preparation, and delivery of controlled pharmaceutical products and related medical equipment to support incarcerated populations and community harm-reduction initiatives. Issuing bodies include state correctional departments and county health authorities, with procurement driven by regulatory requirements to provide medically necessary health care and community health objectives. Suppliers must meet stringent credentialing, clearance, and insurance requirements, and maintain rapid delivery windows—in the case of parenteral nutrition solutions, within 24 hours of order.

Recent activity appears concentrated in the Pacific Northwest and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a response due October 7, 2026, to supply parenteral products including total parenteral nutrition (TPN), peripheral parenteral nutrition (PPN), and intravenous solutions to eight correctional facilities across three regions, with DOC anticipating award to up to three contractors per region and contract performance running through June 30, 2030. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems for quarterly delivery to the county community health building. The Washington solicitation emphasizes small business and minority/women-owned business participation goals and requires documented experience with parenteral product preparation and delivery compliance; the Seminole County procurement requires E-Verify compliance and maintains a three-month probationary termination clause.